208 related articles for article (PubMed ID: 22290424)
41. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
[TBL] [Abstract][Full Text] [Related]
42. Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.
Montazer Haghighi M; Radpour R; Aghajani K; Zali N; Molaei M; Zali MR
Int J Colorectal Dis; 2009 Aug; 24(8):885-93. PubMed ID: 19479271
[TBL] [Abstract][Full Text] [Related]
43. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
Zighelboim I; Powell MA; Babb SA; Whelan AJ; Schmidt AP; Clendenning M; Senter L; Thibodeau SN; de la Chapelle A; Goodfellow PJ
Fam Cancer; 2009; 8(4):501-4. PubMed ID: 19672700
[TBL] [Abstract][Full Text] [Related]
44. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
[TBL] [Abstract][Full Text] [Related]
45. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells.
Mihaylova VT; Bindra RS; Yuan J; Campisi D; Narayanan L; Jensen R; Giordano F; Johnson RS; Rockwell S; Glazer PM
Mol Cell Biol; 2003 May; 23(9):3265-73. PubMed ID: 12697826
[TBL] [Abstract][Full Text] [Related]
46. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.
Chen J; Sadowski I
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865
[TBL] [Abstract][Full Text] [Related]
47. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
[TBL] [Abstract][Full Text] [Related]
48. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
[TBL] [Abstract][Full Text] [Related]
49. DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477).
Weßbecher IM; Hinrichsen I; Funke S; Oellerich T; Plotz G; Zeuzem S; Grus FH; Biondi RM; Brieger A
Mol Carcinog; 2018 Dec; 57(12):1723-1734. PubMed ID: 30136313
[TBL] [Abstract][Full Text] [Related]
50. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
51. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
[TBL] [Abstract][Full Text] [Related]
52. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
Qi Y; Schoene NW; Lartey FM; Cheng WH
J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
[TBL] [Abstract][Full Text] [Related]
53. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
54. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.
Thompson BA; Martins A; Spurdle AB
Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
Hinrichsen I; Weßbecher IM; Huhn M; Passmann S; Zeuzem S; Plotz G; Biondi RM; Brieger A
Mol Carcinog; 2017 Dec; 56(12):2663-2668. PubMed ID: 28767177
[TBL] [Abstract][Full Text] [Related]
56. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma.
Jessri M; Dalley AJ; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):74-82. PubMed ID: 25446502
[TBL] [Abstract][Full Text] [Related]
57. An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers.
Goel A; Nagasaka T; Hamelin R; Boland CR
PLoS One; 2010 Feb; 5(2):e9393. PubMed ID: 20195377
[TBL] [Abstract][Full Text] [Related]
58. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
[TBL] [Abstract][Full Text] [Related]
59. Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line.
Drummond JT; Anthoney A; Brown R; Modrich P
J Biol Chem; 1996 Aug; 271(33):19645-8. PubMed ID: 8702663
[TBL] [Abstract][Full Text] [Related]
60. DNA mismatch repair proteins MLH1 and PMS2 can be imported to the nucleus by a classical nuclear import pathway.
de Barros AC; Takeda AAS; Dreyer TR; Velazquez-Campoy A; Kobe B; Fontes MRM
Biochimie; 2018 Mar; 146():87-96. PubMed ID: 29175432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
